학술논문

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma
Document Type
Article
Source
In Annals of Oncology May 2018 29(5):1266-1272
Subject
Language
ISSN
0923-7534